SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and ...

As I have shown above, it was able to double the percentage gap from placebo with respect to the primary endpoint of reversal of cirrhosis with no worsening of MASH. Going from a separation of ...

Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity Bariatric surgery favorably influences progression of cirrhosis Date: January 27 ...

Many people don’t know they have cirrhosis. Early on it causes only vague symptoms such as weakness or fatigue that a patient might mention to a primary care provider. Blood tests and liver ...

Cirrhosis of the liver describes a progressive condition where scar tissue gradually replaces healthy liver tissue. Health experts may classify cirrhosis into two clinical stages: compensated ...

Yes, metabolic dysfunction-associated steatohepatitis (MASH) can result in cirrhosis of the liver. Formerly known as nonalcoholic steatohepatitis (NASH), MASH describes a type of metabolic ...